Ken Griffin Veru Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Veru Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 102,700 shares of VERU stock, worth $72,917. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,700

Previous 129,300 20.57%

Holding current value

$72,917

Previous $108,000 26.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.76 - $1.79 $6,006 - $14,146	-7,903 Reduced 98.79%	97 $0
Q1 2024 May 15, 2024	BUY	$0.37 - $0.72 $2,960 - $5,760	8,000 New	8,000 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.49 $36,332 - $55,240	-37,074 Reduced 65.99%	19,106 $22,000
Q1 2023 May 15, 2023	SELL	$1.16 - $6.41 $735,781 - $4.07 Million	-634,294 Reduced 91.86%	56,180 $65,000
Q4 2022 Feb 14, 2023	SELL	$4.78 - $15.01 $109,772 - $344,704	-22,965 Reduced 3.22%	690,474 $3.65 Million
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $5.12 Million - $11.9 Million	501,113 Added 236.01%	713,439 $8.22 Million
Q2 2022 Aug 15, 2022	SELL	$4.35 - $15.85 $1.01 Million - $3.68 Million	-232,095 Reduced 52.22%	212,326 $2.4 Million
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $1.5 Million - $2.12 Million	330,423 Added 289.85%	444,421 $2.15 Million
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $946,599 - $1.56 Million	-160,713 Reduced 58.5%	113,998 $671,000
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $1.35 Million - $1.98 Million	199,814 Added 266.79%	274,711 $2.34 Million
Q2 2021 Aug 16, 2021	SELL	$7.24 - $11.2 $4.22 Million - $6.53 Million	-583,244 Reduced 88.62%	74,897 $604,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $4.92 Million - $12.7 Million	610,841 Added 1291.42%	658,141 $7.09 Million
Q4 2020 Feb 16, 2021	BUY	$2.36 - $9.99 $36,735 - $155,504	15,566 Added 49.05%	47,300 $409,000
Q3 2020 Nov 16, 2020	BUY	$2.58 - $3.36 $21,522 - $28,029	8,342 Added 35.66%	31,734 $83,000
Q2 2020 Aug 14, 2020	BUY	$3.01 - $4.02 $33,028 - $44,111	10,973 Added 88.36%	23,392 $78,000
Q1 2020 May 15, 2020	SELL	$2.58 - $4.58 $8,557 - $15,191	-3,317 Reduced 21.08%	12,419 $41,000
Q4 2019 Feb 14, 2020	BUY	$1.86 - $3.35 $4,255 - $7,664	2,288 Added 17.01%	15,736 $53,000
Q3 2019 Nov 14, 2019	BUY	$1.81 - $2.36 $1,218 - $1,588	673 Added 5.27%	13,448 $29,000
Q2 2018 Aug 10, 2018	BUY	$1.64 - $2.29 $20,951 - $29,254	12,775 New	12,775 $0

Others Institutions Holding VERU

# of Institutions

123

Shares Held

56.9M

Call Options Held

668K

Put Options Held

531K

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account